Nkarta, Inc. (NKTX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Nkarta reported revenue of $0. Net income was -$104.1M, or -$1.41 per diluted share. Operating activities generated -$88.7M of cash, leaving -$89.9M of free cash flow. At fiscal year end, Nkarta held $404.2M in total assets against $91.9M in total liabilities, including $39.6M of cash and equivalents.
Open the full interactive Nkarta financials → Quarterly statements, key ratios, valuation history and price charts.
Nkarta Key Stats
| Share Price | $2.10 |
|---|---|
| Market Cap | $156.4M |
| 52-Week Range | $1.73 – $3.67 |
| Shares Outstanding | 74.5 million (basic, 2026 Q2) |
Nkarta Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$51.5M | -$86.4M | -$119.0M | -$131.7M | -$128.2M | -$122.0M |
| Pre-Tax Income | -$91.4M | -$86.1M | -$113.8M | -$117.5M | -$108.8M | -$104.1M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$91.4M | -$86.1M | -$113.8M | -$117.5M | -$108.8M | -$104.1M |
| Diluted EPS | -$5.44 | -$2.62 | -$2.61 | -$2.40 | -$1.60 | -$1.41 |
Nkarta Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$21.7M | -$27.4M | -$27.8M | -$40.4M |
| Diluted EPS | -$0.29 | -$0.37 | -$0.37 | -$0.54 |
Nkarta Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $96.7M | $60.8M | $37.5M | $31.0M | $27.9M | $39.6M |
| Current Assets | $318.8M | $245.8M | $360.7M | $253.1M | $273.3M | $282.5M |
| Total Assets | $337.6M | $273.9M | $472.9M | $378.9M | $501.2M | $404.2M |
| Current Liabilities | $8.8M | $12.9M | $22.0M | $23.3M | $18.9M | $22.3M |
| Total Liabilities | $16.4M | $22.9M | $100.7M | $105.6M | $93.2M | $91.9M |
| Shareholders' Equity | $321.2M | $251.0M | $372.2M | $273.3M | $408.0M | $312.3M |
Nkarta Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$43.5M | -$67.9M | -$57.0M | -$86.2M | -$99.7M | -$88.7M |
| Cash From Investing | -$210.1M | $32.5M | -$184.7M | $79.0M | -$129.6M | $100.3M |
| Cash From Financing | $329.8M | $1.2M | $219.0M | $691,000 | $226.1M | $141,000 |
| Free Cash Flow | -$51.0M | -$73.0M | -$104.1M | -$114.3M | -$104.1M | -$89.9M |
Figures from Nkarta's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Nkarta financials page for every line item.
Nkarta Company Profile
| Ticker | NKTX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | South San Francisco, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001787400 |
Frequently Asked Questions
What was Nkarta's revenue in fiscal 2025?
Nkarta (NKTX) reported revenue of $0 for fiscal 2025.
What is Nkarta's annual revenue history?
Nkarta's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Nkarta's net income in fiscal 2025?
Nkarta reported net income of -$104.1M for fiscal 2025.
What was Nkarta's earnings per share (EPS) in fiscal 2025?
Nkarta's diluted EPS was -$1.41 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Nkarta generate in fiscal 2025?
Nkarta generated -$89.9M of free cash flow in fiscal 2025.
What was Nkarta's revenue last quarter?
In its most recent reported quarter (2026 Q2), Nkarta reported revenue of $0.
How many shares of Nkarta are outstanding?
Nkarta reported a weighted average of 74.5 million basic shares outstanding in 2026 Q2.
What is Nkarta's market cap?
Based on its latest closing price, Nkarta (NKTX) has a market capitalization of about $156.4M.
When does Nkarta's fiscal year end?
Nkarta's fiscal year end, as registered with the SEC, is December 31.
Where is Nkarta headquartered?
Nkarta lists its business address in South San Francisco, California in its SEC filings.